Houston Gene Therapeutics

Houston Gene Therapeutics

At Houston Gene Therapeutics, decades of innovative research drives the development of ambitious therapeutics. The HGT pipeline is pre-FDA approved but composed of long-term treatment options for the major diseases of our time such as inflammatory diseases, aging, and cancer. Founded by Dr. Paul Hermonat, the originator of the AAV-based gene therapy technology. Our flagship HGT-Cardio-1 product treats mice with atherosclerosis, type 2 diabetes, and likely other inflammatory diseases.